Robert C. Doebele, MD, PhD (IMAGE)

University of Colorado Anschutz Medical Campus

Robert C. Doebele, MD, PhD

Caption

Robert C. Doebele, MD, PhD, and colleagues update the effectiveness of entrectinib against ROS1+ and NTRK+ cancers.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.